|
Title
|
|
|
|
Cerebral venous thrombosis in women of childbearing age: diagnosis, treatment, and prophylaxis during a future pregnancy
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Sex-specific risk factors for cerebral venous thrombosis (CVT) in women include oral contraceptives, pregnancy, puerperium, and hormone replacement therapy. The acute treatment of CVT is anticoagulation using therapeutic doses of low molecular weight heparin, which is also the preferred treatment in the post-acute phase in pregnancy and during breastfeeding. In patients with imminent brain herniation decompressive surgery is probably life-saving. A medical history of CVT alone is not a contraindication for future pregnancies. The optimal dosage of low molecular weight heparin as thrombosis prophylaxis during future pregnancies after a history of venous thrombosis including CVT is the topic of an ongoing trial. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Therapeutic advances in neurological disorders. - London, 2008, currens
| |
|
Publication
|
|
|
|
London
:
Sage publications ltd
,
2020
| |
|
ISSN
|
|
|
|
1756-2856
1756-2864
| |
|
DOI
|
|
|
|
10.1177/1756286420945169
| |
|
Volume/pages
|
|
|
|
13
(2020)
, p. 1-8
| |
|
Article Reference
|
|
|
|
1756286420945169
| |
|
ISI
|
|
|
|
000559048700001
| |
|
Medium
|
|
|
|
E-only publicatie
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|